BofA analyst Anna Lizzul raised the firm’s price target on Clorox (CLX) to $112 from $110 and keeps a Neutral rating on the shares after the company reported fiscal Q2 adjusted EPS below the firm’s estimate as gross margin came in below expectations on higher costs. Looking ahead to the second half, the firm maintains “more tepid forecasts” due to uncertainty on improvements in consumption and margins, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: